Navigation Links
Short stature -a problem

Very short children are more likely to suffer from behavioural problems, a major study has found. Researchers found that treatment with growth hormone not only boosted growth in children,// but also improved their conduct and relations with other people.

Lead researcher Dr Derick Beens, professor of psychiatry and pediatrics at the University of North Dakota, said: "We believe this work demonstrates that all very short children need to be evaluated thoroughly by psychologists as well as by paediatricians and endocrinologists."

A sample of 345 short children, aged between five and 16, were tested for intelligence, academic achievement, social skills and behaviour problems before starting growth hormone therapy. They were examined again over a three-year period after starting treatment.

Scientists initially found the children suffered a significant level of emotional and psychological problems including anxiety, depression and attention deficit. Despite achieving lower grades at school, the children had near average IQs, and neither IQ nor achievement test scores changed with treatment.

However, after hormone therapy behaviour problems improved. The children were less anxious, attention improved and they were more open. Dr Beens said: "There are several possible explanations for the improvements.

"One is that growth hormone therapy boosts brain chemicals and neurotransmitters that did not work as well as they would have if hormone secretion had been normal." Behaviour problems in short children improved quickly with six months of hormone replacement therapy, Dr Beens said, but that could not be due to growth alone as height increased slowly.


'"/>




Page: 1

Related medicine news :

1. Bad News for Short People
2. Painkillers Do Not Shorten Dying Patients Lives
3. Short stature -a problem
4. Shortage of MMR vaccine
5. Shorter infants have lower incomes in later life
6. Eye Disorders, A Predictor Of A Shorter Lifespan
7. Shorter Radiation Schedules Found To Be More Effective For Patients With Breast Cancer
8. Short term hormone replacement therapy effective
9. New Eye Surgery Gives Hope To Short-Sighted
10. Short Workouts May Not Prevent Weight Gain And Diseases
11. Short Stature Can Be Treated With A New, Non-Growth Hormone In Future
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Short stature problem

(Date:7/29/2015)... ... July 29, 2015 , ... ... credential for a five-year period, expiring November 30, 2019, during its recent meeting. ... submitting an application demonstrating the program’s compliance with the NCCA’s Standards for the ...
(Date:7/29/2015)... ... July 29, 2015 , ... CrossFit ... name in July to Kalamazoo Strength & Conditioning. , The name change coincides ... the evolution of our training center over the past three years,” according to ...
(Date:7/29/2015)... ... , ... Today marks a significant achievement in bringing new monies into early ... led by a group of experienced investors, has tapped into an investor community passionate ... be a part of the fund. The Sofia Fund II is now closed ...
(Date:7/29/2015)... ... 29, 2015 , ... July is National UV Awareness Month, and in honor of this month, ... how to protect skin from the sun, as well as how to best treat existing ... of the most common skin conditions in America. Many people do not protect their skin ...
(Date:7/29/2015)... ... July 29, 2015 , ... Stealth Therapeutics Inc. announced ... Study for the Invisiport at Wheaton Franciscan Healthcare in Milwaukee, Wis. The Invisiport ... less invasive, patient-friendly alternative to traditional chest ports and peripherally inserted central catheters ...
Breaking Medicine News(10 mins):Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:Sofia Fund Surpasses Investor Goals 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3
... , , ST. PETERSBURG, ... information device franchise, announced today the launch of eMed-Trac, a ... and other cognitive impairments, or children who need to be ... , , The eMed-Trac device ...
... , , NEW YORK, Sept. 16 ... Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for ... it had reached an agreement with the FDA regarding a Special ... in relapsed/refractory multiple myeloma and that the study is expected to ...
... Sept. 16 On September 15, 2009, GenVec, Inc. (Nasdaq: ... stating that the minimum bid price of the Company,s common stock ... that the Company was therefore not in compliance with Marketplace Rule ... the listing of the Company,s common stock on The NASDAQ Global ...
... disease, study finds , TUESDAY, Sept. 15 (HealthDay News) ... with pesticides may be at increased risk for Parkinson,s ... Parkinson,s patients and 511 people without the disease about ... and solvents. Working in agriculture, education, health care or ...
... Beef, dairy most likely to lead to overindulgence, lab study ... stop eating fatty food? Blame your brain, researchers say. , ... fat travel to the brain, which then tell the body ... "Normally, our body is primed to say when we,ve had ...
... ... to Discuss the Latest Research Findings Including: Does a Virus Cause Breast Cancer In ... Belleville, ... www.breasthealthandhealing.com today announced it is collaborating with the Cary Medical Center to ...
Cached Medicine News:Health News:World's First Emergency Medical Information Franchise Launches GPS Tracking Device 2Health News:World's First Emergency Medical Information Franchise Launches GPS Tracking Device 3Health News:World's First Emergency Medical Information Franchise Launches GPS Tracking Device 4Health News:Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma 2Health News:Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma 3Health News:Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma 4Health News:GenVec Receives NASDAQ Notice of Minimum Bid Price Non-Compliance 2Health News:GenVec Receives NASDAQ Notice of Minimum Bid Price Non-Compliance 3Health News:Pesticides Linked to Parkinson's 2Health News:Breast Health and Healing Foundation Convenes Groundbreaking Breast Cancer Summit in Washington D.C. On October 9, 2009 2Health News:Breast Health and Healing Foundation Convenes Groundbreaking Breast Cancer Summit in Washington D.C. On October 9, 2009 3
(Date:7/29/2015)... 29, 2015  Cryoport, Inc. (NASDAQ: ... leading provider of advanced cryogenic logistics solutions ... including immunotherapies, stem cells, cell lines, clinical ... reproductive medicine, announced today that the Company ... warrants (the "Units") under a registered public offering.  ...
(Date:7/29/2015)... , July 29, 2015  Ortho-Clinical Diagnostics, Inc. ... assays under development. The assays address a range of ... injury and cardiac troponin I. The scientific posters will ... Chemistry Annual Meeting to be held July 26 - ... "Ortho Clinical Diagnostics is emerging stronger than ...
(Date:7/29/2015)... July 29, 2015 The Judicial Panel on ... about whether to centralize Inferior vena cava (IVC) Filter ... manufacturer, Cook Medical, have already been centralized by the ... in patients at risk for a pulmonary embolism. The ... to the lungs. Claims against Bard and Cook involve ...
Breaking Medicine Technology:Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3IVC filter litigation continues; law firm provides free information to IVC filter patients 2
... New results from an observational substudy from TRITON–TIMI ... (AHA) Scientific Sessions annual meeting showed that patients ... bypass graft surgery (CABG) had a reduced overall ... (clopidogrel) (2.3 percent versus 8.7 percent respectively, p=0.016).(1) ...
... Nov. 16, 2010 New results from an ... the American Heart Association (AHA) Scientific Sessions annual ... prior to coronary artery bypass graft surgery (CABG) ... patients treated with Plavix® (clopidogrel) (2.3 percent versus ...
Cached Medicine Technology:Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery 2Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery 3Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery 4Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery 5Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery 6Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 2Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 3Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 4Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 5Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 6
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: